Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 305

1.
2.

Disseminated intravascular coagulation or acute coagulopathy of trauma shock early after trauma? An observational study.

Johansson PI, Sørensen AM, Perner A, Welling KL, Wanscher M, Larsen CF, Ostrowski SR.

Crit Care. 2011;15(6):R272. doi: 10.1186/cc10553. Epub 2011 Nov 17.

3.

Evaluation of hemostatic biomarker abnormalities that precede platelet count decline in critically ill patients with sepsis.

Koyama K, Madoiwa S, Tanaka S, Koinuma T, Wada M, Sakata A, Ohmori T, Mimuro J, Nunomiya S, Sakata Y.

J Crit Care. 2013 Oct;28(5):556-63. doi: 10.1016/j.jcrc.2012.10.069. Epub 2013 Apr 9.

PMID:
23583072
4.

Coagulofibrinolytic changes in patients with disseminated intravascular coagulation associated with post-cardiac arrest syndrome--fibrinolytic shutdown and insufficient activation of fibrinolysis lead to organ dysfunction.

Wada T, Gando S, Mizugaki A, Yanagida Y, Jesmin S, Yokota H, Ieko M.

Thromb Res. 2013 Jul;132(1):e64-9. doi: 10.1016/j.thromres.2013.05.010. Epub 2013 May 30.

PMID:
23726093
5.

Markers of acute kidney injury in patients with sepsis: the role of soluble thrombomodulin.

Katayama S, Nunomiya S, Koyama K, Wada M, Koinuma T, Goto Y, Tonai K, Shima J.

Crit Care. 2017 Aug 25;21(1):229. doi: 10.1186/s13054-017-1815-x.

7.

Plasma levels of total plasminogen activator inhibitor-I (PAI-I) and tPA/PAI-1 complex in patients with disseminated intravascular coagulation and thrombotic thrombocytopenic purpura.

Watanabe R, Wada H, Miura Y, Murata Y, Watanabe Y, Sakakura M, Okugawa Y, Nakasaki T, Mori Y, Nishikawa M, Gabazza EC, Shiku H, Nobori T.

Clin Appl Thromb Hemost. 2001 Jul;7(3):229-33.

PMID:
11441985
8.

Prognostic values of the factor Xa-activated clotting time and endogenous thrombin potential in patients suspected of having disseminated intravascular coagulation.

Seo JW, Kim HK, Kim JE, Park S, Cho HI.

Thromb Res. 2009 Feb;123(4):565-72. doi: 10.1016/j.thromres.2008.03.017. Epub 2008 May 13.

PMID:
18479738
9.

Tissue factor pathway inhibitor and P-selectin as markers of sepsis-induced non-overt disseminated intravascular coagulopathy.

Mosad E, Elsayh KI, Eltayeb AA.

Clin Appl Thromb Hemost. 2011 Feb;17(1):80-7. doi: 10.1177/1076029609344981. Epub 2009 Aug 18.

PMID:
19689998
10.

Posttrauma coagulation and fibrinolysis.

Gando S, Tedo I, Kubota M.

Crit Care Med. 1992 May;20(5):594-600.

PMID:
1533358
11.

Diagnosis of pre-disseminated intravascular coagulation stage with hemostatic molecular markers. The Mie DIC Study Group.

Wada H, Wakita Y, Nakase T, Shimura M, Hiyoyama K, Nagaya S, Mori Y, Deguchi K, Shiku H.

Pol J Pharmacol. 1996 Mar-Apr;48(2):225-8.

PMID:
9112656
12.

Normal prothrombinase activity, increased systemic thrombin activity, and lower antithrombin levels in patients with disseminated intravascular coagulation at an early phase of trauma: comparison with acute coagulopathy of trauma-shock.

Yanagida Y, Gando S, Sawamura A, Hayakawa M, Uegaki S, Kubota N, Homma T, Ono Y, Honma Y, Wada T, Jesmin S.

Surgery. 2013 Jul;154(1):48-57. doi: 10.1016/j.surg.2013.02.004. Epub 2013 May 16.

PMID:
23684364
13.

Intravenous immunoglobulin improves sepsis-induced coagulopathy: A retrospective, single-center observational study.

Ishikura H, Nakamura Y, Kawano Y, Tanaka J, Mizunuma M, Ohta D, Nishida T, Murai A.

J Crit Care. 2015 Jun;30(3):579-83. doi: 10.1016/j.jcrc.2015.02.012. Epub 2015 Feb 28.

PMID:
25776897
14.

Thrombin generation mediators and markers in sepsis-associated coagulopathy and their modulation by recombinant thrombomodulin.

Hoppensteadt D, Tsuruta K, Cunanan J, Hirman J, Kaul I, Osawa Y, Fareed J.

Clin Appl Thromb Hemost. 2014 Mar;20(2):129-35. doi: 10.1177/1076029613492875. Epub 2013 Jun 25.

PMID:
23804232
15.

Predicting the severity of systemic inflammatory response syndrome (SIRS)-associated coagulopathy with hemostatic molecular markers and vascular endothelial injury markers.

Iba T, Gando S, Murata A, Kushimoto S, Saitoh D, Eguchi Y, Ohtomo Y, Okamoto K, Koseki K, Mayumi T, Ikeda T, Ishhikura H, Ueyama M, Ogura Y, Endo S, Shimazaki S; Japanese Association for Acute Medicine Disseminated Intravascular Coagulation Study Group.

J Trauma. 2007 Nov;63(5):1093-8.

PMID:
17993956
16.
17.

Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism [ISRCTN74215569].

Kinasewitz GT, Yan SB, Basson B, Comp P, Russell JA, Cariou A, Um SL, Utterback B, Laterre PF, Dhainaut JF; PROWESS Sepsis Study Group.

Crit Care. 2004 Apr;8(2):R82-90. Epub 2004 Feb 10.

18.

Design and Evaluation of New Unified Criteria for Disseminated Intravascular Coagulation Based on the Japanese Association for Acute Medicine Criteria.

Umemura Y, Yamakawa K, Kiguchi T, Yoshikawa Y, Ogura H, Shimazu T, Hamasaki T, Fujimi S.

Clin Appl Thromb Hemost. 2016 Mar;22(2):153-60. doi: 10.1177/1076029615591169. Epub 2015 Jun 13.

PMID:
26072118
19.

Effects of antithrombin and gabexate mesilate on disseminated intravascular coagulation: a preliminary study.

Nishiyama T, Kohno Y, Koishi K.

Am J Emerg Med. 2012 Sep;30(7):1219-23. doi: 10.1016/j.ajem.2011.06.003. Epub 2011 Dec 26.

PMID:
22204993
20.

Activation of the coagulation cascade in patients with leptospirosis.

Chierakul W, Tientadakul P, Suputtamongkol Y, Wuthiekanun V, Phimda K, Limpaiboon R, Opartkiattikul N, White NJ, Peacock SJ, Day NP.

Clin Infect Dis. 2008 Jan 15;46(2):254-60. doi: 10.1086/524664.

PMID:
18171258

Supplemental Content

Support Center